Back
ESC Premium Access

Peak cardiac power output-to-left ventricular mass independently predicted the risk of adverse left ventricular remodeling in patients with heart failure and reduced ejection fraction

Session: Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms
Topic: Ventricular Remodelling
Speaker: Doctor I. Fabiani (Pisa, IT)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Iacopo Fabiani

Fondazione Toscana Gabriele Monasterio, Pisa (Italy)
0 follower

21 more presentations in this session

Effects of mineralocorticoid receptor antagonists on diastolic function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials

Speaker: Associate Professor H. Fukuta (Nagoya, JP)

Access
Abstract
Like
Thumbnail

Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction

Speaker: Doctor K. Kopeva (Tomsk, RU)

Access
Abstract
Slides
Like
Thumbnail

Astragaloside IV reduces cardiac oxidation and improves left ventricular diastolic dysfunction

Speaker: Doctor Q. Wang (Lanzhou, CN)

Access
Abstract
Like
Thumbnail

Long non coding RNA levels in hypertensive patients with heart failure with preserved ejection fraction and their relation to their functional capacity

Speaker: Associate Professor M. Marketou (Heraklion, GR)

Access
Abstract
Slides
Like
Thumbnail

Morphological and functional changes in cardiovascular system in heart failure with preserved ejection fraction.

Speaker: Doctor M. Kurkina (Moscow, RU)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

Speakers: Doctor I. Fabiani, Associate Professor H. Fukuta, Doctor K. Kopeva, Doctor Q. Wang, Associate Professor M. Marketou...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources